Fungal Infection Treatments Washington DC

A drug used to help prevent recurring breast cancer appears to hold promise as a treatment for deadly fungal infections in Washington.

Sakiliba M. Mines
(202) 587-2792
1425 K Street
Washington, MD
Business
The Institute of Multidimensional Medicine PL
Specialties
Family Practice, Cardiovascular Disease Cancer Support
Insurance
Insurance Plans Accepted: Non Participating Provider
Accepts Uninsured Patients: Yes
Emergency Care: No

Doctor Information
Residency Training: Howard University
Medical School: Hanneman Medical College,
Additional Information
Languages Spoken: English,French

Data Provided by:
Konrad L. Dawson
(202) 496-1156
1145 19th Street NW
Washington DC, VA
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Advanced Integrative Rehab & Pain Ctr
(202) 296-3555
908 New Hampshire Ave., NW # 500
Washington, DC

Data Provided by:
Scott L. Spear
(202) 687-8751
3800 Reservoir Road NW
Washington DC, VA
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Franklin R. Polun, DPM
(202) 966-0900
5100 Wisconsin Ave NW
Washington, DC

Data Provided by:
Dr. Stephen J Feinberg
(202) 887-0327
1917 Eye St., NW
Washington, DC

Data Provided by:
David C Johnson, MD
(202) 291-9266
106 Irving St NW
Washington, DC
Business
National Orthopedics PC
Specialties
Orthopedics

Data Provided by:
Washington Chiropractic
(202) 591-3504
5008 Connecticut Ave NW
Washington , DC

Data Provided by:
Chapel Opticians Inc.
(301) 244-0598
6211 Belcrest Road
Hyattsville, MD

Data Provided by:
Suresh R Limaye MD
(703) 931-1515
611 S Carlin Springs Rd
Arlington, VA
Specialties
Ophthalmology

Data Provided by:
Data Provided by:

Fungal Infection Treatments

Provided By:

A drug used to help prevent recurring breast cancer appears to hold promise as a treatment for deadly fungal infections, new research has found.

University of Rochester Medical Center researchers found that tamoxifen kills yeast in mice with Candida infections, which can be fatal to people with compromised immune systems, including people with cancer or HIV and those taking immunosuppressants for chronic conditions.

At extremely high levels, tamoxifen slashed yeast levels by 150-fold, causing most fungus cells to break up and die while halting surviving cells from progressing into a disease-causing state, their study found.

"It's still early, but if tamoxifen, or molecules like it, turns out to be an effective treatment against serious fungal infections, it'll be a welcome addition to our arsenal," Dr. Damian Krysan, an assistant professor of pediatrics at the university and an author of the study, said in a university news release.

The results are published in the August issue of Antimicrobial Agents and Chemotherapy.

Available antifungal medications pose some issues for people who need them the most, according to background information in the news release. The only new class of antifungals approved for use in the past two decades is generally effective, but they can only be taken intravenously, which poses logistic and other problems for some patients. And the most common oral antifungal medication only slows fungus cell growth, making it difficult for immune-compromised patients to completely shake their infections.

"We don't have vaccines against fungal infections, and the few drugs we do have aren't always effective," Krysan said. "We've got a lot more work to do to figure out whether tamoxifen could be used in high doses or whether it could be used in combination with other treatments, but we're excited about the possibility of giving doctors another way to help these critically ill patients."

More information

The U.S. Centers for Disease Control and Prevention has more about Candidiasis.

SOURCE: University of Rochester Medical Center, news release, July 20, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com